Improved NanobodiesTM against Tumor Necrosis Factor-alpha

Details for Australian Patent Application No. 2012200682 (hide)

Owner Ablynx NV

Inventors Beirnaert, Els

Agent Spruson & Ferguson

Pub. Number AU-A-2012200682

Parent 2006249144

Filing date 6 February 2012

Wipo publication date 1 March 2012

International Classifications

C07K 16/18 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies - against material from animals or humans

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

C07K 16/24 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

Event Publications

23 February 2012 Complete Application Filed

1 March 2012 Application Open to Public Inspection

  Published as AU-A-2012200682

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2012200683-Valved fenestrated tracheotomy tube having outer and inner cannulae

2012200681-Metering infrastructure smart cards